Pale Fire Capital SE’s Soleno Therapeutics SLNO Stock Holding History

Pale Fire Capital SE’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,450	Closed	-$283K	–	80
2026 Q1	$283K	Buy	+8,450	New	+$331K	0.02%	46

Pale Fire Capital SE's SLNO Position: Q2 2026 in Review

Pale Fire Capital SE sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 8,450 shares — an estimated $283K sold.

Pale Fire Capital SE first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $283K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Pale Fire Capital SE reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Pale Fire Capital SE sold 8,450 Soleno Therapeutics shares in Q2 2026, an estimated $283K.
Pale Fire Capital SE first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Pale Fire Capital SE's Soleno Therapeutics position peaked at $283K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Pale Fire Capital SE's 13F filing for Q2 2026, filed 13 Aug 2026.